A K Sood1, R E Buller. 1. Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City 52242, USA.
Abstract
OBJECTIVE: To provide a review of the basic mechanisms of drug resistance in ovarian cancer and novel strategies to modulate drug resistance for the general obstetrician-gynecologist. DATA SOURCES: Relevant articles published through December 1996 were identified using the MEDLINE data base. Additional sources were found by cross-referencing. METHODS OF STUDY SELECTION: Publications identified by the search were reviewed and evaluated critically for their relevance to drug resistance in ovarian cancer. TABULATION, INTEGRATION, AND RESULTS: Each reference was reviewed for its contribution to the knowledge regarding mechanisms of chemotherapy resistance in ovarian cancer or strategies to modulate resistance. CONCLUSION: Ovarian cancer patients have high response rates to initial chemotherapy after cytoreductive surgery. However, most will develop resistance to chemotherapy during the course of their treatment. There are multiple mechanisms resulting in drug resistance. Strategies to modulate drug resistance include dose intensity, various pharmacologic agents, and gene therapy.
OBJECTIVE: To provide a review of the basic mechanisms of drug resistance in ovarian cancer and novel strategies to modulate drug resistance for the general obstetrician-gynecologist. DATA SOURCES: Relevant articles published through December 1996 were identified using the MEDLINE data base. Additional sources were found by cross-referencing. METHODS OF STUDY SELECTION: Publications identified by the search were reviewed and evaluated critically for their relevance to drug resistance in ovarian cancer. TABULATION, INTEGRATION, AND RESULTS: Each reference was reviewed for its contribution to the knowledge regarding mechanisms of chemotherapy resistance in ovarian cancer or strategies to modulate resistance. CONCLUSION:Ovarian cancerpatients have high response rates to initial chemotherapy after cytoreductive surgery. However, most will develop resistance to chemotherapy during the course of their treatment. There are multiple mechanisms resulting in drug resistance. Strategies to modulate drug resistance include dose intensity, various pharmacologic agents, and gene therapy.
Authors: Lingegowda S Mangala; Vesna Zuzel; Rosemarie Schmandt; Erik S Leshane; Jyotsna B Halder; Guillermo N Armaiz-Pena; Whitney A Spannuth; Takemi Tanaka; Mian M K Shahzad; Yvonne G Lin; Alpa M Nick; Christopher G Danes; Jeong-Won Lee; Nicholas B Jennings; Pablo E Vivas-Mejia; Judith K Wolf; Robert L Coleman; Zahid H Siddik; Gabriel Lopez-Berestein; Svetlana Lutsenko; Anil K Sood Journal: Clin Cancer Res Date: 2009-05-26 Impact factor: 12.531
Authors: Andrew Schrepf; Premal H Thaker; Michael J Goodheart; David Bender; George M Slavich; Laila Dahmoush; Frank Penedo; Koen DeGeest; Luis Mendez; David M Lubaroff; Steven W Cole; Anil K Sood; Susan K Lutgendorf Journal: Psychoneuroendocrinology Date: 2015-01-20 Impact factor: 4.905
Authors: Laura Martín de la Fuente; Susanne Malander; Linda Hartman; Jenny-Maria Jönsson; Anna Ebbesson; Mef Nilbert; Anna Måsbäck; Ingrid Hedenfalk Journal: Int J Gynecol Pathol Date: 2018-03 Impact factor: 2.762